Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in Patients With Locally Advanced Pancreatic Cancer A Prospective, Single-arm, Phase II Trial
Latest Information Update: 04 Jul 2024
At a glance
- Drugs Cadonilimab (Primary) ; Capecitabine; Fluorouracil; Folinic acid; Gimeracil/oteracil/tegafur; Irinotecan; Oxaliplatin
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Therapeutic Use
Most Recent Events
- 04 Jun 2024 Status changed from not yet recruiting to recruiting.
- 04 Jun 2024 Results assessing efficacy and safety of combining cadonilimab with modified FOLFIRINOX for the treatment of LAPC presented at the 60th Annual Meeting of the American Society of Clinical Oncology
- 04 Dec 2023 New trial record